RxDoctor Payments Data

Aalia Al-Barwani

Family Medicine · Houston, TXNPI 1437388352

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Novo Nordisk accounts for 79.8% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $279 and has fallen 58.1% since, to $117 in 2025.

$594in general payments, 2019–2025

Across 10 payments — averaging $59.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$475
  • Medtronic$86
  • Pfizer$20
  • Cranial Technologies, Inc$13
$6,789,306in research payments, 2019–2025

Across 91 payments — averaging $74,608 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$5.9M
  • Modernatx, Inc.$808K
  • Genentech, Inc.$33K

What the payments were for

  • Food & beverage$594100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk6$475
Medtronic1$86
Pfizer2$20
Cranial Technologies, Inc1$13

How this compares

$594 in reported general payments places this provider in the 55th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Other family medicine in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →